Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Insulin Icodec Weekly: A Basal Insulin Analogue for Type 2 Diabetes
View through CrossRef
Insulin icodec is a once-weekly basal insulin analogue in late-phase clinical development. Similar efficacy and safety of icodec to once-daily basal insulin analogues have been reported in over 4,200 participants with type 2 diabetes from three phase II and five phase III trials. Indeed, glycated haemoglobin reduction was superior for icodec among insulin-naïve participants (ONWARDS 1, 3 and 5) and in those switching from a daily basal insulin in ONWARDS 2, with the latter trial demonstrating improved diabetes treatment satisfaction scores with insulin icodec versus insulin degludec.
Title: Insulin Icodec Weekly: A Basal Insulin Analogue for Type 2 Diabetes
Description:
Insulin icodec is a once-weekly basal insulin analogue in late-phase clinical development.
Similar efficacy and safety of icodec to once-daily basal insulin analogues have been reported in over 4,200 participants with type 2 diabetes from three phase II and five phase III trials.
Indeed, glycated haemoglobin reduction was superior for icodec among insulin-naïve participants (ONWARDS 1, 3 and 5) and in those switching from a daily basal insulin in ONWARDS 2, with the latter trial demonstrating improved diabetes treatment satisfaction scores with insulin icodec versus insulin degludec.
Related Results
Appraisal of Once-Weekly Insulin Icodec
Appraisal of Once-Weekly Insulin Icodec
Insulin icodec is a long-acting basal insulin analog under development that can be administered once weekly. The main purpose of this article is to provide an appraisal on insulin ...
Once-weekly Insulin Icodec – An emerging treatment option for type 2 Diabetes
Once-weekly Insulin Icodec – An emerging treatment option for type 2 Diabetes
The treatment of diabetes often necessitates the administration of exogenous insulin, but research shows that patients are less compliant with administering insulin daily. The main...
Navigating the Efficacy-Safety Trade-off of Once-Weekly Insulin Icodec in Clinical Practice
Navigating the Efficacy-Safety Trade-off of Once-Weekly Insulin Icodec in Clinical Practice
The recent FDA approval of insulin icodec (Awiqli) on 26 March 2026- the first once-weekly basal insulin for adults with type 2 diabetes(T2D), marks a significant advancement in in...
Exploring the Efficacy of Once and Twice Weekly Thyroxine Dosing: A Promising Approach for Hypothyroidism Management
Exploring the Efficacy of Once and Twice Weekly Thyroxine Dosing: A Promising Approach for Hypothyroidism Management
Abstract
Introduction
Hypothyroidism is a common endocrine disorder, in which the management involves daily intake of thyroxine. However, adherence to a daily medication regimen po...
Insulin icodec: A novel once‐weekly treatment for diabetes
Insulin icodec: A novel once‐weekly treatment for diabetes
Abstract
Aims
To summarize the results of clinical studies of insulin icodec, an investigational insulin analog designed ...
Efficacy and safety of once-weekly insulin icodec compared to once-daily insulin g U-100 in patients with type II diabetes: a systematic review and meta-analysis
Efficacy and safety of once-weekly insulin icodec compared to once-daily insulin g U-100 in patients with type II diabetes: a systematic review and meta-analysis
Abstract
Background//Objective
Diabetes affects millions of people globally, despite treatment options, adherence and other factors pose obstacles. ...
Diabetes Mellitus: Life Style, Obesity and Insulin Resistance
Diabetes Mellitus: Life Style, Obesity and Insulin Resistance
In millennia, 40 million people were died with non-communicable diseases and diabetes is one of them. In diabetes, insulin secretions are not produced properly or resist to body an...
(Invited) A Protein-Based Artificial Receptor for Insulin Sensing
(Invited) A Protein-Based Artificial Receptor for Insulin Sensing
Insulin is one of the most important hormones that controls the glucose level in blood. Therefore, the investigation of insulin is very important for the diabetic research. There h...